Blood Transfusion Test Company Quotient Files for Bankruptcy

Quotient Ltd., a publicly traded blood transfusion diagnostics company, filed for Chapter 11 bankruptcy in Texas on Tuesday.

• The company reported assets of about $128 million and liabilities of about $310 million as of Sept. 31, according to its bankruptcy petition
• Quotient in December signed a transaction support agreement with certain senior secured and convertible noteholders that calls for restructuring the company’s balance sheet, per court papers
• The case is Quotient Limited, 23-90003, U.S. Bankruptcy Court for the Southern District of Texas (Houston)

To contact the reporter on this story:
Jeremy Hill in New York at jhill273@bloomberg.net

To contact the ...